We are live on ! Find out more
AIG

American International Group Portfolio holdings

AUM $609M
1-Year Est. Return 23.67%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
-23.67%
3 Year Est. Return
+19.07%
5 Year Est. Return
+37.34%
10 Year Est. Return
+206.83%
AUM
$28.5M
AUM Growth
+$1.53M
Cap. Flow
-$722M
Cap. Flow %
-2,531.03%
Top 10 Hldgs %
18.22%
Holding
3,207
New
56
Increased
1,695
Reduced
1,371
Closed
37

Sector Composition

Rank Sector Weight
1 Technology 19.93%
2 Healthcare 13.38%
3 Financials 10.47%
4 Consumer Discretionary 10.45%
5 Industrials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNB
2951
DELISTED
Dun & Bradstreet
DNB
$57 ﹤0.01%
2,378
+754
+46% +$18.1K
ABTC
2952
American Bitcoin Corp
ABTC
$471M
0
CORR
2953
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$57 ﹤0.01%
8,000
+21
+0.3% +$168
CDAK
2954
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$57 ﹤0.01%
3,749
+521
+16% +$11.3K
CDTX
2955
DELISTED
Cidara Therapeutics
CDTX
$56 ﹤0.01%
1,050
+3
+0.3% +$148
CG icon
2956
Carlyle Group
CG
$17.2B
$56 ﹤0.01%
1,529
-137
-8% -$4.8K
RITM icon
2957
Rithm Capital
RITM
$5.69B
$56 ﹤0.01%
4,958
-411
-8% -$4.18K
RETA
2958
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$56 ﹤0.01%
558
-15
-3% -$1.75K
MDLA
2959
DELISTED
Medallia, Inc.
MDLA
$56 ﹤0.01%
2,000
-189
-9% -$7.01K
FHTX icon
2960
Foghorn Therapeutics
FHTX
$360M
$55 ﹤0.01%
4,192
+11
+0.3% +$180
KRMD icon
2961
KORU Medical Systems
KRMD
$164M
$55 ﹤0.01%
15,712
+41
+0.3% +$178
NYMX
2962
DELISTED
Nymox Pharmaceutical Corp
NYMX
$55 ﹤0.01%
24,649
+65
+0.3% +$171
NC icon
2963
NACCO Industries
NC
$320M
$54 ﹤0.01%
2,182
+6
+0.3% +$147
QVCGA
2964
DELISTED
QVC Group Inc Series A
QVCGA
$54 ﹤0.01%
91
-8
-8% -$4.93K
SBT
2965
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$54 ﹤0.01%
9,538
+24
+0.3% +$125
GBT
2966
DELISTED
Global Blood Therapeutics, Inc.
GBT
$54 ﹤0.01%
1,331
-159
-11% -$7.31K
CIZN
2967
DELISTED
Citizens Holding Co.
CIZN
$54 ﹤0.01%
2,728
+7
+0.3% +$143
AXS icon
2968
AXIS Capital
AXS
$7.55B
$53 ﹤0.01%
1,070
-94
-8% -$4.71K
HLF icon
2969
Herbalife
HLF
$1.29B
$53 ﹤0.01%
1,202
-109
-8% -$5.38K
LAZ icon
2970
Lazard
LAZ
$4.31B
$53 ﹤0.01%
1,207
-100
-8% -$4.25K
XAIR icon
2971
Beyond Air
XAIR
$3.86M
$53 ﹤0.01%
24
+3
+14% +$7.28K
GRA
2972
DELISTED
W.R. Grace & Co.
GRA
$53 ﹤0.01%
883
-90
-9% -$5.37K
AUBN icon
2973
Auburn National Bancorp
AUBN
$91.9M
$52 ﹤0.01%
1,364
+3
+0.2% +$123
AZEK
2974
DELISTED
The AZEK Co
AZEK
$52 ﹤0.01%
1,243
+185
+17% +$7.91K
CMRC
2975
Commerce.com Inc Series 1
CMRC
$184M
$52 ﹤0.01%
897
+614
+217% +$40.8K

Similar funds

American International Group's Q1 2021 Portfolio in Review

As of Q1 2021, American International Group held 3,207 positions worth $28.5M, up 5.7% from $27M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

American International Group withdrew a net $722M in Q1 2021, closing 37 positions and reducing 1,371 holdings. Its most notable exit was Eidos Therapeutics, Inc. Common Stock, an estimated $27.2K position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

Against the trend, American International Group opened a new position in NOV worth $1.64K.

  • American International Group's largest Q1 2021 buy was NOV: 119,500 shares worth $1.64K.
  • American International Group added most to SQZ Biotechnologies Company in Q1 2021, an estimated $51.1M increase.
  • American International Group's biggest Q1 2021 reduction was JPMorgan Chase, cutting an estimated $38.2M.
  • American International Group fully exited Eidos Therapeutics, Inc. Common Stock in Q1 2021, selling an estimated $27.2K.
  • American International Group's ten largest holdings make up 18% of its $28.5M portfolio in Q1 2021.
  • American International Group opened 56 new positions and closed 37 in Q1 2021.
  • American International Group's portfolio value rose 5.7% quarter-over-quarter to $28.5M.

Based on American International Group's 13F filing for Q1 2021, filed 7 May 2021.